SP Elixir (OPC) Private Limited

Imbruvica (Ibrutinib) 120 mg Capsules are a medication used primarily to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström's macroglobulinemia, and small lymphocytic lymphoma (SLL). Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor, which works by blocking the BTK enzyme, a critical part of the signaling pathway that helps cancer cells survive and proliferate. By inhibiting this enzyme, Imbruvica helps to slow down or stop the growth of cancer cells. It is typically taken orally once daily, and the dosage may vary depending on the condition being treated. Regular monitoring of blood counts and other side effects is important during treatment.